Insmed Incorporated INSM
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Gavin Clark-Gartner |
Evercore ISI |
146.3138 $ |
180 $ |
33.69 % |
01/10/2025 |
| Tiago Fauth |
Wells Fargo |
122 $ |
140 $ |
18.00 % |
12/08/2025 |
| Graig Suvannavejh |
Mizuho Securities |
73.43 $ |
92 $ |
18.57 % |
15/08/2024 |
| Tiago Fauth |
Wells Fargo |
71.81 $ |
85 $ |
13.19 % |
09/08/2024 |
| Vamil Divan |
Guggenheim |
70.05 $ |
95 $ |
24.95 % |
09/07/2024 |
| Nicole Germino |
Truist Financial |
67 $ |
88 $ |
21.00 % |
01/07/2024 |
| Leon Wang |
Barclays |
69.71 $ |
90 $ |
20.29 % |
25/06/2024 |
| Liisa Bayko |
Evercore ISI |
66.19 $ |
75 $ |
8.81 % |
21/06/2024 |
| Graig Suvannavejh |
Mizuho Securities |
57.17 $ |
82 $ |
24.83 % |
07/06/2024 |
| Stephen Willey |
Stifel Nicolaus |
57 $ |
74 $ |
17.00 % |
05/06/2024 |
| Tiago Fauth |
Wells Fargo |
53.55 $ |
77 $ |
23.45 % |
29/05/2024 |
| Andrew Fein |
H.C. Wainwright |
48.06 $ |
70 $ |
21.94 % |
29/05/2024 |
| Trung Huynh |
UBS |
48.06 $ |
58 $ |
9.94 % |
29/05/2024 |
| Nicole Germino |
Truist Financial |
48.06 $ |
68 $ |
19.94 % |
29/05/2024 |
| Andy Chen |
Wolfe Research |
48.06 $ |
54 $ |
5.94 % |
29/05/2024 |
| Jeffrey Hung |
Morgan Stanley |
48.06 $ |
60 $ |
11.94 % |
28/05/2024 |
| Andrea Tan |
Goldman Sachs |
46.39 $ |
74 $ |
27.61 % |
28/05/2024 |
| Liisa Bayko |
Evercore ISI |
46.2099 $ |
42 $ |
-4.21 % |
28/05/2024 |
| Graig Suvannavejh |
Mizuho Securities |
25.33 $ |
36 $ |
10.67 % |
13/05/2024 |
| Jeffrey Hung |
Morgan Stanley |
26.38 $ |
43 $ |
16.62 % |
09/05/2024 |
| Nicole Germino |
Truist Financial |
24.11 $ |
48 $ |
23.89 % |
23/04/2024 |
| Tiago Fauth |
Wells Fargo |
27.13 $ |
55 $ |
27.87 % |
01/04/2024 |